Alpha 2.0
Login Register
» Authors » Ruby Huang

Ruby Huang

Explore the profile of Ruby Huang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 82
Followers 0
Related Specialties
General Medicine
Oncology
Cell Biology
Top 10 Co-Authors
Joel A Malek
Eliane Mery
Arash Rafii
Jean-Paul Thiery
Denis Querleu
Eva Jouve
Anja Rockstroh
Liuliu Pan
Elizabeth M Swisher
Wah-Seng Lim
Published In
Dev Cell
J Transl Med
Leuk Lymphoma
Ther Adv Med Oncol
PLoS One
Affiliations
Soon will be listed here.
Recent Articles
1.
Whole transcriptome profiling of placental pathobiology in SARS-CoV-2 pregnancies identifies placental dysfunction signatures
Stylianou N, Sebina I, Matigian N, Monkman J, Doehler H, Rohl J, et al.
Clin Transl Immunology . 2024 Feb; 13(2):e1488. PMID: 38322491
Objectives: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus infection in pregnancy is associated with higher incidence of placental dysfunction, referred to by a few studies as a 'preeclampsia-like syndrome'....
2.
The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models
Ho G, Vandenberg C, Lim R, Christie E, Garsed D, Lieschke E, et al.
Ther Adv Med Oncol . 2023 Nov; 15:17588359231208674. PMID: 38028140
Background: Despite initial response to platinum-based chemotherapy and PARP inhibitor therapy (PARPi), nearly all recurrent high-grade serous ovarian cancer (HGSC) will acquire lethal drug resistance; indeed, ~15% of individuals have...
3.
Gene expression analysis of matched ovarian primary tumors and peritoneal metastasis
Malek J, Martinez A, Mery E, Ferron G, Huang R, Raynaud C, et al.
J Transl Med . 2012 Jun; 10:121. PMID: 22687175
Background: Ovarian cancer is the most deadly gynecological cancer due to late diagnosis at advanced stage with major peritoneal involvement. To date most research has focused on primary tumor. However...
4.
Copy number variation analysis of matched ovarian primary tumors and peritoneal metastasis
Malek J, Mery E, Mahmoud Y, Al-Azwani E, Roger L, Huang R, et al.
PLoS One . 2011 Dec; 6(12):e28561. PMID: 22194851
Ovarian cancer is the most deadly gynecological cancer. The high rate of mortality is due to the large tumor burden with extensive metastatic lesion of the abdominal cavity. Despite initial...
5.
Schedule- and dose-dependency of CPX-351, a synergistic fixed ratio cytarabine:daunorubicin formulation, in consolidation treatment against human leukemia xenografts
Lim W, Tardi P, Xie X, Fan M, Huang R, Ciofani T, et al.
Leuk Lymphoma . 2010 Jun; 51(8):1536-42. PMID: 20528246
CPX-351, a liposomal formulation co-encapsulating cytarabine (Cyt) and daunorubicin (Daun), has been developed, which delivers synergistic Cyt:Daun molar ratios to bone marrow. CPX-351 has demonstrated markedly superior anti-leukemic activity over...
6.
Linking epithelial-mesenchymal transition to the well-known polarity protein Par6
Thiery J, Huang R
Dev Cell . 2005 Apr; 8(4):456-8. PMID: 15809027
Epithelial-mesenchymal transition (EMT) is involved in the formation of the body plan, tissue remodeling, and cancer progression. Two recent reports in Science (Barrios-Rodiles et al., 2005; Ozdamar et al., 2005)...